Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Larimar Therapeutics Inc’s current trading price is -57.21% away from its 52-week high, while its distance from the 52-week low is 152.48%. The stock’s price range during this period has varied between $1.61 and $9.50. The company, active in the Healthcare sector, saw a trading volume of around 4.35 million for the day, considerably higher average daily volume of 1.24 million observed over the last three months.
Larimar Therapeutics Inc (LRMR) has a current stock price of $4.06. During the previous trading session, the stock witnessed a notable rise, reaching a high of $40.0 after opening at $4.08. The stock’s low for the day was $10.0, and it eventually closed at $3.31.
The stock market performance of Larimar Therapeutics Inc has been very steady.
How Financial Performance Impacts Market Capitalization
Larimar Therapeutics Inc (LRMR) has experienced a quarterly rise of 51.11% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 336.48M and boasts a workforce of 65 employees.
Decoding Analysts’ Ratings for Larimar Therapeutics Inc
As of right now, 10 analysts are rating Larimar Therapeutics Inc as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.60, with a change in price of +1.27. Similarly, Larimar Therapeutics Inc recorded 1,237,001 in trading volume during the last 100 days, posting a change of +47.40%.
How LRMR’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for LRMR stands at 0.03. Similarly, the long-term debt-to-equity ratio is also 0.03.
LRMR Stock Stochastic Average
As of today, the raw stochastic average of Larimar Therapeutics Inc over the past 50 days is 97.96%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 95.03%. Additionally, the Stochastic %K and %D values for the company were 53.56% and 46.92%, respectively, over the past 20 days.
LRMR Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. The index has shown a price loss of -51.14% this year. Over the last six months, there has been a weaker performance of 14.50%. The price of LRMR fallen by 27.03% during the last 30 days period. For the last 5-days stocks have improved 15.15%.
